North America Epinephrine Market to Grow at a CAGR of 8.5% to reach US$ 1,598.99 million from 2019 to 2027

North America Epinephrine Market to 2027 - Regional Analysis and Forecasts by Product Type (Prefilled Syringes, Auto-Injectors, Ampoules and Vials); Application (Anaphylaxis, Superficial Bleeding, Respiratory Disorders, Cardiac Arrest); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); and Country

Publication Month: Mar 2020 | Report Code: TIPRE00009746 | No. of Pages: 126 | Category: Chemicals and Materials | Status: Published
Covid

The North America epinephrine market is expected to reach US$ 1,598.99 Mn in 2027 from US$ 841.86 Mn in 2019. The market is estimated to grow with a CAGR of 8.5% from 2019-2027.

 

The growth of the market is driven by factors such as the fast growth of auto-injector production in North America and the growing prevalence of anaphylaxis cases in the North American region. Whereas, lack of availability of epinephrine drug is likely to have a negative impact on the growth of the market in the coming years.

 

Anaphylaxis is a severe, lifethreatening allergic reaction characterized by symptoms such as skin redness and itching, swallowing and breathing difficulties, wheezing, rapid breathing rate (tachypnoea), accelerated heart rate (tachycardia), and falling blood pressure. It may involve multiple systems of human body. Anaphylaxis is caused by exposure to an allergen (foods, insect stings, or medicines) that is recognized as a non-self by a human body.

The incidence of anaphylaxis is increasing, as per Allergy Facts by the American College of Allergy, Asthma & Immunology, and more than 50 million Americans experience different types of allergies every year. Moreover, it also lists allergies as the sixth-leading cause of chronic illness in the US and the most common health issues in children. In 2015, 8.2% of adults and 8.4% of children were diagnosed with hay fever. According to the Asthma and Allergy Foundation of America, in the last few years, hospital visits have also increased due to food allergic reaction. According to Food Allergy Research & Education, ~32 million Americans are living with life-threatening food allergies, and there are 200,000 visits to the emergency room every year due to food allergies. Allergies put an economic burden on healthcare systems in many countries; for example, according to Allergy Facts, the annual cost of managing the cases of allergies is more than USD 18 billion in the US. Anaphylaxis requires immediate medical treatment, and it can turn lethal if not treated properly. ~90–100 Americans die every year due to anaphylaxis caused by insect stings.

Therefore, the demand for epinephrine is expected to increase during the forecast period.

The rising number of the anaphylaxis cases in North America is expected to drive epinephrine market growth as Americans are more prone to allergy and infections. As in other North American countries, US faces a continuous and significant increase in the number of anaphylaxis cases. This rising number of the anaphylaxis cases and the growing pharmaceutical industry in the country create a lucrative opportunity and the presence of an established market for epinephrine.

 

Mexico Epinephrine Market Revenue and Forecasts to 2027 (US$ Bn)

Mexico Epinephrine Market Revenue and Forecasts to 2027 (US$ Bn)

Get more information on this report :



NORTH AMERICA EPINEPHRINE– MARKET SEGMENTATION

North America Epinephrine Market - By Product Type

  • Prefilled Syringes
  • Auto-Injectors
  • Ampoules and Vials

 

North America Epinephrine Market - By Application

  • Anaphylaxis
  • Superficial Bleeding
  • Respiratory Disorders
  • Cardiac Arrest


North America Epinephrine Market - By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies


North America Epinephrine Market - By Country

  • US
  • Canada
  • Mexico


Companies Mentioned

  • Mylan N.V.
  • Teva Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals LLC
  • ALK-Abelló A/S
  • Abbott
  • Kaleo, Inc
  • BIOPROJET
  • Medeca Pharma AB
  • Novartis AG
  • Erythpharm

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Epinephrine Market – By Product Type

1.3.2        North America Epinephrine Market – By Application

1.3.3        North America Epinephrine Market – By Distribution Channel

1.3.4        North America Epinephrine Market – By Country

2.           North America Epinephrine Market –  Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Epinephrine Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Epinephrine Market - North America PEST Analysis

4.3         Expert Opinion

5.           North America Epinephrine Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Fast growth of Auto-injector production

5.1.2        Increasing Prevalence Of Anaphylaxis Cases

5.2         Key Restraints

5.2.1        Lack of Availability of Epinephrine

5.3         Key Market Opportunities

5.3.1        Growing Pipeline of Epinephrine

5.4         Future Trend

5.4.1        Novel Drug Delivery Systems

5.5         Impact Analysis

6.           Epinephrine Market – North America Analysis

6.1         North America Epinephrine Market Revenue Forecasts and Analysis

6.2         Positioning Of Key Players

7.           North America Epinephrine Market Analysis And Forecasts To 2027 – Product Type

7.1         Overview

7.2         North America Epinephrine Market, By Product Type 2019 & 2027 (%)

7.2.1        North America Epinephrine Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.3         Auto-Injectors

7.3.1        Overview

7.3.2        North America Auto-Injectors Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Prefilled Syringes

7.4.1        Overview

7.4.2        North America Prefilled Syringes Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Ampoules and Vials

7.5.1        Overview

7.5.2        North America Ampoules and Vials Market Revenue and Forecasts to 2027 (US$ Mn)

8.           North America Epinephrine Market Analysis– By Application

8.1         Overview

8.2         North America Epinephrine Market, By Application 2019-2027 (%)

8.2.1        North America Epinephrine Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Anaphylaxis

8.3.1        Overview

8.3.2        North America Anaphylaxis Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Cardiac Arrest

8.4.1        Overview

8.4.2        North America Cardiac Arrest Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Respiratory Disorders

8.5.1        Overview

8.5.2        North America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Superficial Bleeding

8.6.1        Overview

8.6.2        North America Superficial Bleeding Market Revenue and Forecasts to 2027 (US$ Mn)

9.           North America Epinephrine Market Analysis– By Distribution Channel

9.1         Overview

9.2         North America Epinephrine Market, By Distribution Channel 2019-2027 (%)

9.2.1        North America Epinephrine Market Revenue and Forecasts to 2027, By Distribution Channel Application (US$ Mn)

9.3         Retail Pharmacies

9.3.1        Overview

9.3.2        North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Online Pharmacies

9.5.1        Overview

9.5.2        North America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Epinephrine Market Revenue And Forecasts To 2027  Geographical Analysis

10.1      North America Epinephrine Market Revenue and Forecasts To 2027

10.1.1     Overview

10.1.2     North America Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)

10.1.3     North America Epinephrine Market, Revenue and Forecast to 2027, by Product Type (US$ Mn)

10.1.4     North America Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)

10.1.5     North America Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)

10.1.6     North America Epinephrine Market, Revenue and Forecast to 2027, by Country (%)

10.1.7     United States

10.1.7.1       US Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)

10.1.7.2       US Epinephrine Market, Revenue and Forecast to 2027, by Product Type (US$ Mn)

10.1.7.3       US Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)

10.1.7.4       US Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)

10.1.8     Canada

10.1.8.1       Canada Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)

10.1.8.2       Canada Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)

10.1.8.3       Canada Epinephrine Market, Revenue and Forecast to 2027, by Application(US$ Mn)

10.1.8.4       Canada Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)

10.1.9     Mexico

10.1.9.1       Mexico Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)

10.1.9.2       Mexico Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)

10.1.9.3       Mexico Epinephrine Market, Revenue and Forecast to 2027, by Application(US$ Mn)

10.1.9.4       Mexico Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)

11.        North America Epinephrine Market –Industry Landscape

11.1      Overview

11.2      Growth Strategies In The Epinephrine Market, 2015-2019

11.3      Organic Growth Strategies

11.3.1     Overview

11.4      Inorganic Growth Strategies

11.4.1     Overview

11.5      Intranasal Epinephrine Spray–Clinical Trials

11.5.1     Overview

12.        North America Epinephrine Market- Key Company Profiles

12.1      ALK-Abelló A/S

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Amneal Pharmaceuticals, Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Kaleo, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Teva Pharmaceutical Industries Ltd

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      BIOPROJET

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Medeca Pharma AB

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Novartis AG

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      MYLAN N.V.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Erythpharm

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.            North America Epinephrine Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 2.            North America Epinephrine Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.            North America Epinephrine Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 4.            North America Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)

Table 5.            North America Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)

Table 6.            North America Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)

Table 7.            US Epinephrine Market Revenue and Forecast To 2027, by Product Type(US$ Mn)

Table 8.            US Epinephrine Market, Revenue and Forecast To 2027, by Application (US$ Mn)

Table 9.            US Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)

Table 10.         Canada Epinephrine Market Revenue and Forecast To 2027, by Product Type (US$ Mn)

Table 11.         Canada Epinephrine Market Revenue and Forecast To 2027, by Application (US$ Mn)

Table 12.         Canada Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)

Table 13.         Mexico Epinephrine Market Revenue and Forecast To 2027, by Product Type (US$ Mn)

Table 14.         Mexico Epinephrine Market Revenue and Forecast To 2027, by Application (US$ Mn)

Table 15.         Mexico Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)

Table 16.         Recent Organic Growth Strategies in the Epinephrine market

Table 17.         Recent Inorganic Growth Strategies In The Epinephrine Market

Table 18.         Developments For The Intranasal Epinephrine Spray, By Companies

Table 19.         Glossary of Terms, Epinephrine Market

LIST OF FIGURES

Figure 1.          Epinephrine Market Segmentation

Figure 2.          North America Epinephrine Market Overview

Figure 3.          Auto-injectors Segment Held Largest Share Of Product type Segment In Epinephrine Market

Figure 4.          North America Epinephrine Market- Leading Country Markets (US$ Mn)

Figure 5.          North America Epinephrine Market, Industry Landscape

Figure 6.          Epinephrine Market - North America PEST Analysis

Figure 7.          Epinephrine Market Impact Analysis of Drivers And Restraints

Figure 8.          North America Epinephrine Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          Market Positioning Of Key Players In North America Epinephrine Market

Figure 10.       North America Epinephrine Market, by Product Type 2019 & 2027 (%)

Figure 11.       North America Auto-Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.       North America Prefilled Syringes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.       North America Ampoules and Vials Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.       North America Epinephrine Market, by Application 2019 & 2027 (%)

Figure 15.       North America Anaphylaxis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.       North America Cardiac Arrest Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.       North America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.       North America Superficial Bleeding Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.       North America Epinephrine Market, by Distribution Channel 2019 & 2027 (%)

Figure 20.       North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.       North America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       North America Epinephrine Market, Revenue by Country (2019) (US$ Mn)

Figure 24.       North America Epinephrine Market Revenue and Forecast to 2027 (US$ Mn)

Figure 25.       North America Epinephrine Market, Revenue and Forecast to 2027, by Country (%)

Figure 26.       US Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)

Figure 27.       Canada Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)

Figure 28.       Mexico Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)

Figure 29.       Growth Strategies In The Epinephrine Market, 2015-2019

 

The List of Companies - North America Epinephrine Market

  1. Mylan N.V.
  2. Teva Pharmaceuticals Ltd.
  3. Amneal Pharmaceuticals LLC
  4. ALK-Abelló A/S
  5. Abbott
  6. Kaleo, Inc
  7. BIOPROJET
  8. Medeca Pharma AB
  9. Novartis AG
  10. Erythpharm

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America epinephrine market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America epinephrine market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00009746
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing